Viking Therapeutics, Inc (VKTX) Total Assets by Year
Viking Therapeutics, Inc closed fiscal year 2025 with $715.7M in total assets, $76.7M in total liabilities and $639.1M in shareholder equity. This represents a decrease of 21.2% from the prior fiscal year. The table below carries 12 fiscal years, from 2014 to 2025, and the quarters Viking Therapeutics, Inc has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
VKTX Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2510-K | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $715.7M-21.2% | $908.3M+146.5% | $368.5M+118.7% | $168.5M-20.0% | $210.7M-17.9% | $256.5M-9.8% | $284.3M-6.0% | $302.3M+1266.6% | $22.1M+52.2% | $14.5M-5.9% | $15.4M+407.3% | $3.0M |
| Total Liabilities | $76.7M+173.4% | $28.0M+39.7% | $20.1M-13.5% | $23.2M+164.4% | $8.8M-27.8% | $12.2M+70.4% | $7.1M+56.4% | $4.6M-47.3% | $8.7M+33.3% | $6.5M-3.3% | $6.7M-73.3% | $25.2M |
| Total Equity | $639.1M-27.4% | $880.3M+152.6% | $348.4M+139.8% | $145.3M-28.0% | $201.9M-17.4% | $244.3M-11.8% | $277.1M-6.9% | $297.8M+2111.5% | $13.5M+67.4% | $8.0M-7.8% | $8.7M+139.4% | -$22.1M |
VKTX Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q2'2610-Q | Q1'2610-Q | Q4'2510-Q | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-K | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $521.9M-37.0% | $608.2M-29.8% | $715.7M-21.2% | $739.4M-21.2% | $827.9M-12.6% | $867.0M-10.4% | $908.3M+146.5% | $937.9M+145.1% | $946.8M+136.3% | $967.5M+541.2% | $368.5M+118.7% | $382.7M+129.6% |
| Total Liabilities | $113.6M+250.7% | $106.3M+429.6% | $76.7M+173.4% | $26.4M-0.2% | $32.4M+25.3% | $20.1M-40.3% | $28.0M+39.7% | $26.4M+83.3% | $25.9M+77.4% | $33.6M+99.8% | $20.1M-13.5% | $14.4M-6.3% |
| Total Equity | $408.3M-48.7% | $501.9M-40.7% | $639.1M-27.4% | $713.0M-21.8% | $795.5M-13.6% | $846.9M-9.3% | $880.3M+152.6% | $911.4M+147.5% | $921.0M+138.5% | $933.9M+596.6% | $348.4M+139.8% | $368.2M+143.4% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Viking Therapeutics, Inc financials
Frequently Asked Questions
What was Viking Therapeutics, Inc's total assets in fiscal year 2025?
Viking Therapeutics, Inc closed fiscal year 2025 with $715.7M in total assets, $76.7M in total liabilities and $639.1M in shareholder equity.
How fast is Viking Therapeutics, Inc's total assets growing?
Viking Therapeutics, Inc (VKTX) total assets fell by 21.2% year over year, from $908.3M to $715.7M in fiscal year 2025.
How has Viking Therapeutics, Inc's total assets changed over the years?
Across the 12 fiscal years this page covers, Viking Therapeutics, Inc (VKTX) total assets went from $3.0M in fiscal year 2014 to $715.7M in fiscal year 2025.
What was Viking Therapeutics, Inc's total assets in the most recent quarter?
Viking Therapeutics, Inc (VKTX) reported $521.9M in total assets in Q2 2026. This represents a decrease of 37.0% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Viking Therapeutics, Inc (VKTX) reported on that line in every period on record.